日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Nafamostat Mesilate as an Anticoagulation Strategy for Heparin-Induced Thrombocytopenia: A Case Report

萘莫司他甲磺酸盐作为肝素诱导血小板减少症的抗凝策略：病例报告

期刊:Journal of Blood Medicine
影响因子:2.7
doi:10.2147/JBM.S564615
Mei, Shuqin; Xue, Cheng; Liu, Lingling; Cui, Linlin; Lv, Jiayi; Ruan, Mengna; Mao, Zhiguo; Lu, Chunlai; Sun, Lijun; Dai, Bing
血小板
发表日期：2026
文献求助 收藏

PRMT1-mediated methylation of UBE2m promoting calcium oxalate crystal-induced kidney injury by inhibiting fatty acid metabolism.

PRMT1介导的UBE2m甲基化通过抑制脂肪酸代谢促进草酸钙晶体引起的肾损伤

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07888-3
Yuan Tianhui, Ye Zehua, Mei Shuqin, Zhang Miao, Wu Ming, Lin Fangyou, Yu Weimin, Li Wei, Zhou Xiangjun, Cheng Fan
代谢
肾损伤
DNA甲基化
DNA甲基化
发表日期：2025
文献求助 收藏

Unraveling the Genetic Links Between Polycystic Kidney Disease and Hypertension Through ARL13B

通过 ARL13B 基因揭示多囊肾病与高血压之间的遗传联系

期刊:International Journal of Nephrology and Renovascular Disease
影响因子:2.5
doi:10.2147/IJNRD.S550416
Chen, Juan; Song, Lei; Mei, Shuqin; Huang, Jing; Fu, Lili; Zhou, Chenchen; Hu, Xiaohua; Zhang, Liming; Xue, Cheng; Mao, Zhiguo
心血管
高血压
发表日期：2025
文献求助 收藏

Gene therapy in polycystic kidney disease: A promising future

基因疗法在多囊肾病中的应用：前景光明

期刊:Journal of Translational Internal Medicine
影响因子:7.4
doi:10.1515/jtim-2024-0021
Xue, Cheng; Lv, Jiayi; Yang, Bo; Mei, Shuqin; Xu, Jing; Li, Xinming; Zhang, Liming; Mao, Zhiguo
发表日期：2024
文献求助 收藏

Durable response to pembrolizumab in hepatic metastasis from colonic carcinoma with Lynch syndrome: a case report

帕博利珠单抗治疗伴有林奇综合征的结肠癌肝转移患者获得持久疗效：病例报告

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1455907
Xue, Cheng; Zhu, Dongqing; Wang, Xin; Jiao, Lina; Lu, Yunhui; Zhang, Sanli; Lv, Jiayi; Cui, Linlin; Ruan, Mengna; Xu, Dechao; Liu, Qingyang; Feng, Yun; Mei, Shuqin
肿瘤
肠癌
肿瘤免疫
发表日期：2024
文献求助 收藏

COVID-19-Associated Immune Thrombocytopenic Purpura in a Hemodialysis Patient

一名血液透析患者出现与 COVID-19 相关的免疫性血小板减少性紫癜

期刊:Journal of Blood Medicine
影响因子:2.7
doi:10.2147/JBM.S496127
Mei, Shuqin; Xue, Cheng; Zhang, Zheng; Liu, Lingling; Cai, Wenwen; Gong, Xuelian; Mao, Zhiguo; Tang, Xiaojing; Dai, Bing
血小板
免疫/内分泌
发表日期：2024
文献求助 收藏

Susceptibility of renal fibrosis in diabetes: Role of hypoxia inducible factor-1

糖尿病肾纤维化的易感性：缺氧诱导因子-1的作用

期刊:FASEB Journal
影响因子:4.2
doi:10.1096/fj.202200845R
Mei, Shuqin; Li, Lin; Zhou, Xiangjun; Xue, Cheng; Livingston, Man J; Wei, Qingqing; Dai, Bing; Mao, Zhiguo; Mei, Changlin; Dong, Zheng
糖尿病
代谢
发表日期：2022
文献求助 收藏

Thrombotic thrombocytopenic purpura developed after pegylated interferon treatment for hepatitis B infection

乙型肝炎感染患者接受聚乙二醇干扰素治疗后出现血栓性血小板减少性紫癜

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-022-03034-9
Mei, Shuqin; Feng, Yun; Cui, Linlin; Chen, Jing; Mao, Zhiguo; Zhao, Xuezhi; Mei, Changlin; Qian, Yixin
炎症/感染
心血管
肝炎
血小板
发表日期：2022
文献求助 收藏

A 64-year-old woman with raccoon eyes following kidney biopsy: a case report

一名64岁女性肾活检后出现熊猫眼：病例报告

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-020-01770-4
Mei, Shuqin; Zhao, Yunyang; Li, Lin; Mei, Changlin; Dai, Bing
发表日期：2020
文献求助 收藏

Induction of microRNA-17-5p by p53 protects against renal ischemia-reperfusion injury by targeting death receptor 6

p53诱导microRNA-17-5p的表达，通过靶向死亡受体6来保护肾脏免受缺血再灌注损伤。

期刊:Kidney International
影响因子:12.6
doi:10.1016/j.kint.2016.07.017
Hao, Jielu; Wei, Qingqing; Mei, Shuqin; Li, Lin; Su, Yunchao; Mei, Changlin; Dong, Zheng
信号转导
发表日期：2017
文献求助 收藏